Altamira Therapeutics获日本鼻内贝他司汀配方专利许可

华尔街洞察
Jul 15, 2025

Altamira Therapeutics Ltd.宣布,日本专利局已批准其关于鼻内贝他司汀二盐酸盐配方的专利申请。此次专利覆盖了公司AM-125项目的组成和使用方法,该项目专注于治疗急性前庭综合征。目前,Altamira Therapeutics已在全球超过50个国家获得专利保护。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10